Executive - Manufacturing (Fractionation)

Intas Pharmaceuticals; Ahmedabad District; On-site; INR 600,000 - 800,000; Full time

Job summary

Intas Pharmaceuticals is seeking an Executive - Manufacturing (Fractionation) to support plasma fractionation operations at our Ahm unit. The role demands hands-on work with centrifuges, filtration systems, and chromatography, plus CIP/SIP and autoclave activities.

You should bring 2–4 years of fractionation/upstream process experience, with strong SOP, training, and documentation skills. This is a full-time on-site position at Plasma Fractionation Unit, Ahm, Gujarat, 382210.

Qualifications

• M.Sc Biotechnology or B.Tech Biotechnology degree.
• 2–4 years of experience in fractionation/upstream processes.

Responsibilities

• Hands-on experience on centrifuges, filtration systems, and chromatography.
• Handling CIP & SIP activities; supporting the manufacturing team.
• Handling autoclave and integrity activities; SOP preparation, training, and documentation.

Skills

Problem Solving

Action Oriented

Dealing with Ambiguity

Customer Focus

Time Management

Education

M.Sc Biotechnology

B.Tech Biotechnology

Job description

Recruitment Fraud Disclaimer

Intas does not request or accept any fees during recruitment. If someone asks for payment on our behalf, it is a scam. Please report the incident to the local police or cybercrime unit. Your trust and safety are important to us.

About Intas

Intas is a leading global pharmaceutical company specializing in the development, manufacturing, and marketing of pharmaceutical formulations. The mission of the company is to address unmet medical and societal needs through a fully integrated pharmaceutical value chain spanning across the world. Through its subsidiaries, the International presence of Intas includes the following countries: over 85 worldwide, with some of the more important global markets like North America, Europe, Latin America, and the Asia-Pacific under the well-known brand name Accord Healthcare. The rapid expansion has been due to organic growth and strategic acquisitions alone, vindicating its position in some of the important major pharmaceutical markets across the world. Intas follows high standards of quality, as reflected by products approved for leading global regulatory agencies including USFDA, MHRA, and EMA. Substantial in-house R&D capability, along with the beginning of a focus on highly advanced areas like Biosimilars and New Chemical Entities-Intas continues to push the frontiers of excellence in healthcare. At Intas, our success is fundamentally built on the strength of our people. Our ongoing commitment is to attract and retain the best talent in the industry while fostering an empowering environment that encourages innovation and excellence. This approach ensures that every employee plays a meaningful role in driving both the company’s growth and advancements in global healthcare.

Job Title: Executive - Manufacturing (Fractionation)

Job Requisitions No.: 18011

Job Description

Competencies

• Intas - Problem Solving
• Intas - Action Oriented
• Intas - Dealing with Ambiguity
• Intas - Customer Focus
• Intas - Time Management

Roles and Responsibilities

• Hands-on Experience on Centrifuges, Filteration Systems, Chromatography.
• Handling of CIP & SIP Activities. Supporting to the Manufacturing Team.
• Handling of Autoclave & Integrity Activies.
• Sop Preparation, Training & Documentation.

Qualification Required

• M.Sc Biotechnology
• B.Tech Biotechnology

Relevant Skills / Industry Experience

Experience : 2-4 Years ( Fractionation | Upstream Process )

Relevant professional / Educational background

Location

Plasma Fractionation Unit, Ahm, GJ, IN, 382210

Travel

0%

Life at Intas Pharmaceuticals

For over three decades, Intas has thrived due to the exceptional talent of its people. Our growth is fueled by a dynamic environment that nurtures individual potential while fostering collaboration and collective success. We believe that when diverse skills and perspectives unite under a shared purpose and value system, we can achieve remarkable outcomes, driving innovation and excellence across the pharmaceutical landscape.

Date: 31 Aug 2026